<DOC>
	<DOCNO>NCT00113620</DOCNO>
	<brief_summary>The purpose study determine whether dextromethorphan ( Neurodex ) quinidine effective treatment pain diabetic neuropathy .</brief_summary>
	<brief_title>Safety Efficacy Dextromethorphan Quinidine Treatment Pain Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Quinidine</mesh_term>
	<mesh_term>Quinidine gluconate</mesh_term>
	<criteria>Diagnosis diabetes mellitus Established diabetic therapy least 3 month Labsupported diagnosis painful diabetic distal symmetric sensory/motor polyneuropathy Pain previous three month Not pregnant Patient fail adequate trial 3 medication require narcotic pain History torsades de pointes Sensitivity quinidine opiate drug ( codeine , etc ) Severe pain could confound assessment Patient amputation Patient participate past 30 day currently participate another trial Patient previously receive treatment dextromethorphan quinidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>distal symmetrical</keyword>
	<keyword>pain</keyword>
	<keyword>low extremity</keyword>
	<keyword>dextromethorphan</keyword>
</DOC>